To obtain a compound having both a muscarine receptor antagonism and a peripheral nerve tetrodotoxin-insensitive Na+-channel inhibitory action as a compound to be expected to have a strong ameliorating action on symptoms of an overactive bladder syndrome, especially urge to urinate.

The optically active substance of a quinazolinone derivative is represented by formula (1) or its pharmaceutically acceptable salt.